FLT3 plays an important but not exclusive role in maintaining the survival of normal HSCs, and its recurrent mutations, either as internal tandem duplications (ITD) or in the tyrosine kinase domain (TDK), are found in many AML cases [89,90]. The gene discussed is FLT3; the disease is acute myeloid leukemia.